Corticosteroid vs. Amniotic Fluid Injections in Patients With Trigger Finger

Status unconfirmed · Phase 3

Conditions studied: Stenosing Tenosynovitis

In brief

The proposed study aims to investigate whether amniotic fluid injections are a better alternative to corticosteroid injections as a conservative treatment for stenosing tenosynovitis. Based on results from our most recent pilot study exploring patient outcomes after receiving an amnion injection, we were able to observe symptom resolution in more than half of the study population. Adverse events were extremely rare and not related to study participation. Given the numerous occurrences of successful symptom resolution, the next step is to compare patient outcomes to those of patients who receive the standard steroid injection. This study will compare outcome measurements of patients who receive amnion injections to those who receive steroid injections.

Key facts

Study ID

NCT03583151

Run by

J&M Shuler

People needed

100

Starts

2018-05-10

Expected to finish

2019-12-01

Last updated by the study team

2018-07-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is at least 18 years of age
• Patient is diagnosed with stenosing tenosynovitis

You may not qualify if…

• Patient is less than 18 years of age
• Pregnancy
• Enrolling clinician does not believe that the patient is mentally capable of understanding the research nature of the procedure due to mental handicap/disability or illiteracy.

Where it is running

• Athens Orthopedic Clinic — Athens, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.